Work

Abstract 6695: Early progression disadvantage of immunotherapy-only treatment versus chemotherapy in NSCLC: A meta-analysis of randomized controlled trials

Year: 2026
Type: review
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: closed
OpenAlex ID: W7148827209
FWCI:
Cites:
Cited by:
Related to: